Bicara Therapeutics Inc.
BCAX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002023658
In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Bicara Therapeutics Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 145 | 2 | 171 | +28 |
| Shares | 68.9M | 3.34M | 69.8M | +4.27M (+6.5%) |
| Value | $1.35B | $66.4M | $2.07B | +$789.2M (+61.6%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (39)
Institutions that held Bicara Therapeutics Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (11)
Institutions that held Bicara Therapeutics Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| HRT Financial LP | 40,209 | $799.0K |
| Caption Management, LLC | 23,000 | $457.5K |
| Balyasny Asset Management LLC | 21,797 | $433.5K |
| Susquehanna International Group, LLP | 10,944 | $217.7K |
| Squarepoint Ops LLC | 10,771 | $214.2K |
| Thrive Wealth Management, LLC | 10,344 | $205.7K |
| Group One Trading, L.P. | 1,306 | $26.0K |
| MAI Capital Management | 57 | $1.13K |
| Root Financial Partners, LLC | 29 | $577 |
| Quadrant Capital Group LLC | 13 | $259 |
| Swiss Life Asset Management Ltd | 8,651 | – |
Not filed for Q2 2026 yet (2)
Institutions that held Bicara Therapeutics Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 3,339,218 | $66.4M |
| CWM, LLC | 1,138 | $22.6K |